Carmell (CTCX) Competitors $0.32 -0.01 (-2.99%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CTCX vs. OM, MDAI, IRIX, XAIR, NXL, POCI, LFWD, NRXS, NXGL, and BSGMShould you be buying Carmell stock or one of its competitors? The main competitors of Carmell include Outset Medical (OM), Spectral AI (MDAI), IRIDEX (IRIX), Beyond Air (XAIR), Nexalin Technology (NXL), Precision Optics (POCI), ReWalk Robotics (LFWD), NeurAxis (NRXS), NEXGEL (NXGL), and BioSig Technologies (BSGM). These companies are all part of the "medical equipment" industry. Carmell vs. Outset Medical Spectral AI IRIDEX Beyond Air Nexalin Technology Precision Optics ReWalk Robotics NeurAxis NEXGEL BioSig Technologies Outset Medical (NASDAQ:OM) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their community ranking, dividends, profitability, media sentiment, institutional ownership, risk, analyst recommendations, earnings and valuation. Does the media prefer OM or CTCX? In the previous week, Outset Medical had 2 more articles in the media than Carmell. MarketBeat recorded 2 mentions for Outset Medical and 0 mentions for Carmell. Outset Medical's average media sentiment score of 0.28 beat Carmell's score of -1.00 indicating that Outset Medical is being referred to more favorably in the media. Company Overall Sentiment Outset Medical Neutral Carmell Negative Do analysts prefer OM or CTCX? Outset Medical currently has a consensus price target of $4.70, indicating a potential upside of 670.49%. Given Outset Medical's higher probable upside, research analysts plainly believe Outset Medical is more favorable than Carmell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Outset Medical 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Carmell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has preferable valuation and earnings, OM or CTCX? Carmell has lower revenue, but higher earnings than Outset Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOutset Medical$130.38M0.24-$172.80M-$3.14-0.19Carmell$12.32K551.47-$15.44MN/AN/A Is OM or CTCX more profitable? Carmell has a net margin of 0.00% compared to Outset Medical's net margin of -136.72%. Outset Medical's return on equity of -143.52% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets Outset Medical-136.72% -143.52% -48.89% Carmell N/A -148.47%-40.47% Do institutionals & insiders hold more shares of OM or CTCX? 24.2% of Carmell shares are owned by institutional investors. 3.5% of Outset Medical shares are owned by company insiders. Comparatively, 29.0% of Carmell shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in OM or CTCX? Outset Medical received 24 more outperform votes than Carmell when rated by MarketBeat users. CompanyUnderperformOutperformOutset MedicalOutperform Votes2439.34% Underperform Votes3760.66% CarmellN/AN/A Which has more volatility & risk, OM or CTCX? Outset Medical has a beta of 1.95, meaning that its share price is 95% more volatile than the S&P 500. Comparatively, Carmell has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. SummaryOutset Medical beats Carmell on 8 of the 14 factors compared between the two stocks. Ad Timothy SykesCountdown to the biggest trade of my 25 yr careerTim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why Get Carmell News Delivered to You Automatically Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTCX vs. The Competition Export to ExcelMetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.79M$4.45B$5.40B$8.53BDividend YieldN/A42.37%5.15%4.14%P/E RatioN/A36.56112.5515.07Price / Sales551.4764.751,478.8293.55Price / CashN/A49.2739.8334.04Price / Book0.304.214.645.01Net Income-$15.44M$11.52M$119.13M$225.46M7 Day Performance-7.14%1.05%0.78%0.37%1 Month Performance-7.14%0.94%5.65%3.57%1 Year Performance-84.52%39.40%36.90%29.42% Carmell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTCXCarmell1.0637 of 5 stars$0.33-3.0%N/A-83.8%$6.79M$12,320.000.0014Negative NewsOMOutset Medical2.2769 of 5 stars$0.54-1.8%$4.70+770.5%-83.8%$28.12M$116.43M-0.17520Upcoming EarningsMDAISpectral AI2.3991 of 5 stars$1.56+8.3%$4.50+188.5%-51.5%$27.27M$22.53M-1.1678Upcoming EarningsGap DownIRIXIRIDEX1.0829 of 5 stars$1.60-0.6%$2.00+25.0%-30.1%$26.01M$49.70M-2.42120Analyst ForecastShort Interest ↑Gap UpXAIRBeyond Air4.5283 of 5 stars$0.52+8.3%$3.67+606.2%-79.0%$24.15M$1.78M-0.3270Gap UpHigh Trading VolumeNXLNexalin Technology1.359 of 5 stars$2.28-12.6%$3.00+31.6%+887.5%$24.15M$110,000.00-3.173News CoverageGap UpPOCIPrecision Optics0.9267 of 5 stars$3.77-2.1%N/A-29.1%$23.94M$19.10M-7.6980Positive NewsLFWDReWalk Robotics3.5522 of 5 stars$2.31-2.1%$13.00+462.7%N/A$19.87M$23.28M-0.7660Short Interest ↓News CoverageNRXSNeurAxisN/A$2.69-6.6%N/A+9.3%$18.41M$2.27M-0.9119NXGLNEXGEL1.3022 of 5 stars$2.88flatN/A+44.0%$18.20M$4.09M-5.0510Gap DownHigh Trading VolumeBSGMBioSig TechnologiesN/A$1.11+11.0%N/A-75.9%$18.14M$40,000.000.0050Gap Down Related Companies and Tools Related Companies OM Alternatives MDAI Alternatives IRIX Alternatives XAIR Alternatives NXL Alternatives POCI Alternatives LFWD Alternatives NRXS Alternatives NXGL Alternatives BSGM Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CTCX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
